Laser light could reveal kidney transplant health in real time
NCT ID NCT07753434
First seen Aug 07, 2026 · Last updated Aug 07, 2026
Summary
This study is testing whether a laser imaging technique, called laser speckle contrast imaging, can predict how well a new kidney will work after a transplant. The technique measures blood flow in the tiny blood vessels of the kidney during surgery. Researchers will compare these images with the kidney's function in the days after the operation to see if the imaging can spot early signs of problems.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- laser speckle contrast imaging (LSCI) device
- What this could lead to
- If successful, this imaging technique could help doctors predict early kidney function after transplant, potentially improving patient care.
- What could go wrong
- This is an observational study, so it cannot prove cause and effect. The results may not apply to all transplant patients, and the imaging technique's predictive value is still uncertain.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Participants
-
80 people
The number who actually took part.
- Started
-
Aug 2024
- Finished
-
Feb 2025
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
Who is studied
Patients who underwent renal transplantation at our hospital between August 2024 and February 2025.
- Ages
-
Children (under 18), adults (18 to 64) and older adults (65 and over)
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Patients undergoing renal transplantation in our hospital. Exclusion Criteria: * Patients who need reoperation within 7 days after initial renal transplantation. * Patients with acute rejection within 24 hours after operation.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Postoperative renal function are added.
Genom att skicka in godkänner du våra Användarvillkor
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
The Second Affiliated Hospital of Chongqing Medical University
Chongqing, Chongqing Municipality, 400010, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.